R. Theriault

1.6k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

R. Theriault is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, R. Theriault has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in R. Theriault's work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (7 papers) and Bone health and treatments (5 papers). R. Theriault is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (7 papers) and Bone health and treatments (5 papers). R. Theriault collaborates with scholars based in United States, Canada and United Kingdom. R. Theriault's co-authors include G. N. Hortobágyi, R S Walters, Frankie A. Holmes, A. U. Buzdar, D. Frye, Martin N. Raber, Rena Vassilopoulou‐Sellin, Richard L. Theriault, Vicente Valero and Giuseppe Fraschini and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Oncology.

In The Last Decade

R. Theriault

24 papers receiving 1.3k citations

Hit Papers

Phase II Trial of Taxol, ... 1991 2026 2002 2014 1991 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
    1991 615 citations Frankie A. Holmes, R S Walters et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Theriault United States 13 970 439 264 166 162 25 1.3k
Laura Pizzuti Italy 23 906 0.9× 410 0.9× 454 1.7× 140 0.8× 333 2.1× 96 1.7k
Gisele Sarosy United States 21 810 0.8× 231 0.5× 654 2.5× 220 1.3× 225 1.4× 38 1.7k
D. Frye United States 12 1.5k 1.5× 708 1.6× 304 1.2× 120 0.7× 401 2.5× 22 1.9k
Akiyo Yoshimura Japan 18 508 0.5× 352 0.8× 377 1.4× 177 1.1× 279 1.7× 67 1.2k
Volker Möbus Germany 26 1.2k 1.2× 587 1.3× 493 1.9× 227 1.4× 312 1.9× 117 2.2k
Chantal Bernard-Marty Belgium 14 845 0.9× 441 1.0× 280 1.1× 96 0.6× 247 1.5× 22 1.2k
A. U. Buzdar United States 18 1.2k 1.3× 930 2.1× 379 1.4× 264 1.6× 299 1.8× 46 2.1k
Cristina Noberasco Italy 20 751 0.8× 374 0.9× 399 1.5× 291 1.8× 337 2.1× 75 1.5k
G. Catimel France 21 1.3k 1.3× 339 0.8× 521 2.0× 125 0.8× 395 2.4× 45 1.7k
Cecilia Nisticò Italy 23 1.2k 1.2× 555 1.3× 306 1.2× 100 0.6× 403 2.5× 70 1.6k

Countries citing papers authored by R. Theriault

Since Specialization
Citations

This map shows the geographic impact of R. Theriault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Theriault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Theriault more than expected).

Fields of papers citing papers by R. Theriault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Theriault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Theriault. The network helps show where R. Theriault may publish in the future.

Co-authorship network of co-authors of R. Theriault

This figure shows the co-authorship network connecting the top 25 collaborators of R. Theriault. A scholar is included among the top collaborators of R. Theriault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Theriault. R. Theriault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, J., Haidy Metwally, R. Theriault, et al.. (2023). LMJSSP for analysis of prophylactic lubricants, spermicides and residues. Talanta. 266(Pt 1). 124959–124959. 2 indexed citations
2.
Theriault, R., et al.. (2021). Metabolomics patterns of breast cancer tumors using mass spectrometry imaging. International Journal of Computer Assisted Radiology and Surgery. 16(7). 1089–1099. 11 indexed citations
3.
4.
Theriault, R., et al.. (2012). Biology of Bone Metastases. Cancer Control. 19(2). 92–101. 79 indexed citations
5.
Theriault, R., Jennifer K. Litton, Elizabeth A. Mittendorf, et al.. (2011). Age and Survival Estimates in Patients Who Have Node-Negative T1ab Breast Cancer by Breast Cancer Subtype. Clinical Breast Cancer. 11(5). 325–331. 62 indexed citations
6.
Theriault, R. & Jennifer K. Litton. (2011). Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies. Yearbook of Oncology. 2011. 7–9. 1 indexed citations
7.
Ottesen, Rebecca A., et al.. (2008). Continued use of trastuzumab (TRZ) beyond disease progression in the National Comprehensive Cancer Network (NCCN). Journal of Clinical Oncology. 26(15_suppl). 6522–6522. 4 indexed citations
8.
9.
Bookman, Michael A., et al.. (2003). Emergence of Sentinel Node Biopsy in Breast Cancer as Standard-of-Care in Academic Comprehensive Cancer Centers. JNCI Journal of the National Cancer Institute. 95(20). 1514–1521. 87 indexed citations
10.
Coleman, RE, Justus Apffelstaedt, Domonick K Gordon, et al.. (2001). Zometa® is effective and well tolerated in the prevention of skeletal related events secondary to metastatic breast cancer treated with hormonal therapy. European Journal of Cancer. 37. S152–S152. 4 indexed citations
11.
Holmes, Frankie A., Vicente Valero, R S Walters, et al.. (1999). Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results. Annals of Oncology. 10(4). 403–411. 14 indexed citations
12.
Hortobágyi, Gabriel N., Lon A. Porter, R. Theriault, et al.. (1996). PP-8-9 Reduction of skeletal related complications in breast cancer patients with osteolytic bone metastases receiving chemotherapy (CT), by monthly pamidronate sodium (PAM) (AREDIA®) infusion. European Journal of Cancer. 32. 50–50. 1 indexed citations
13.
14.
Holmes, Frankie A., Timothy Madden, Robert A. Newman, et al.. (1996). Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.. Journal of Clinical Oncology. 14(10). 2713–2721. 142 indexed citations
15.
Carlson, Robert W., Lori J. Goldstein, WJ Gradishar, et al.. (1996). NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network.. PubMed. 10(11 Suppl). 47–75. 41 indexed citations
16.
Theriault, R., et al.. (1995). Differentiating inflammatory breast cancer from acute mastitis.. PubMed. 52(3). 929–34. 23 indexed citations
17.
Valero, Vicente, R S Walters, R. Theriault, et al.. (1993). Phase II study of taxotere in refractory metastatic breast cancer (RMBC). European Journal of Cancer. 29. S83–S83. 14 indexed citations
18.
Vassilopoulou‐Sellin, Rena, et al.. (1992). Acute Thyroid Dysfunction (Thyroiditis) after Therapy with Interleukin-2. Hormone and Metabolic Research. 24(9). 434–438. 30 indexed citations
19.
Holmes, Frankie A., R S Walters, R. Theriault, et al.. (1991). Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer. JNCI Journal of the National Cancer Institute. 83(24). 1797–1805. 615 indexed citations breakdown →
20.
Theriault, R.. (1990). Management of hypercalcemia in breast cancer.. PubMed. 4(2). 43–6; discussion 50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Pizzuti Breakdown of academic impact, for papers by Gisele Sarosy Breakdown of academic impact, for papers by D. Frye Breakdown of academic impact, for papers by Akiyo Yoshimura Breakdown of academic impact, for papers by Volker Möbus Breakdown of academic impact, for papers by Chantal Bernard-Marty Breakdown of academic impact, for papers by A. U. Buzdar Breakdown of academic impact, for papers by Cristina Noberasco Breakdown of academic impact, for papers by G. Catimel Breakdown of academic impact, for papers by Cecilia Nisticò
Rankless by CCL
2026